The prime focus of Cellphire is the industrialization of its proprietary cell stabilization technology. Cellphire, together with its partner BARDA are actively engaged on the development of Thrombosomes® for application in battlefield & disaster applications.

Cellphire has partnerships with leading blood banks to ensure safe & secure sourcing for all its products.


Partnering Opportunities

Cellphire is actively seeking partners within industry to evaluate applications for stabilized platelets in a wide range of clinical, therapeutic and diagnostic fields. The ability to stabilize and store platelets at ambient temperatures as a dry powder which upon reconstitution exhibits the same functionality as fresh platelets offers potential solutions to current unmet needs in the fields of hematology, vascular surgery, invasive radiology, wound management, plastic surgery, veterinary medicine, targeted drug delivery and clinical & research diagnostics.

Have Questions?Reach us here

Please enter your information below

The Cellphire Method

Cellphire has developed a proprietary method for the stabilization of blood cells in the dry state. The first application of this technology is to develop long term stabilization of platelets as a hemostatic agent.